![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
EU WC
0
Listed Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. Benzylcetyldimethylammonium
2. Benzylcetyldimethylammonium Chloride Hydrate
3. Bzk-c16
1. 10328-34-4
2. Cetyldimethylbenzylammonium
3. Cetalkonium Ion
4. Cetalkonium Cation
5. Benzyl-hexadecyl-dimethylazanium
6. Benzyldimethylhexadecylammonium
7. Benzylhexadecyldimethylammonium
8. Benzenemethanaminium, N-hexadecyl-n,n-dimethyl-
9. Fhg725432z
10. Benzylcetyldimethylammonium
11. Unii-fhg725432z
12. Benzyldimethylhexadecyl Ammonium
13. Cbnbr
14. Benzyl Hexadecyl Dimethyl Ammonium
15. Benzyl-hexadecyl-dimethyl-ammonium
16. Benzyldimethylhexadecylammonium Cation
17. Benzylcetyldimethylaminium
18. Schembl233796
19. Chembl1624075
20. Dtxsid3047007
21. Benzalkonium Chloride C16
22. Chebi:135523
23. Zinc14233334
24. Db11583
25. A901252
26. Sr-01000944408
27. Sr-01000944408-1
28. Q27277991
29. Benzenemethanaminium, N-hexadecyl, N,n-dimethyl-
30. 51895-89-7
Molecular Weight | 360.6 g/mol |
---|---|
Molecular Formula | C25H46N+ |
XLogP3 | 9.5 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 0 |
Rotatable Bond Count | 17 |
Exact Mass | 360.363025472 g/mol |
Monoisotopic Mass | 360.363025472 g/mol |
Topological Polar Surface Area | 0 Ų |
Heavy Atom Count | 26 |
Formal Charge | 1 |
Complexity | 291 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Cetalkonium is used as a surfactant, germicide, fungicide, mildew preventive agents in silicone-based water repellents, emulsifier, disinfectant, topical anti-infective, and antiseptic antimicrobial for pharmaceuticals. For its chemical properties and its antiseptical characteristics, cetalkonium can be used in a wide variety of products as part of the formulations and it is also determined to be an active antiseptic ingredient in over-the-counter preparations.
Cetalkonium is an antimicrobial agent and it has shown to be effective against both gram-positive, gram-negative bacteria and fungi. From this property, it has been shown to present a better activity against the gram-negative organisms.
Absorption
Cetalkonium is used mainly topically and it is not absorbed. When administered orally and parenterally, cetalkonium absorption may happen but it is very insignificant.
Route of Elimination
As cetalkonium is not absorbed, this pharmacokinetic property is not relevant. When administered orally, most of the administered dose is excreted unchanged in the feces as it is very poorly absorbed.
Volume of Distribution
As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.
Clearance
As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.
As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.
As cetalkonium is not absorbed, this pharmacokinetic property is not relevant.
The activity of cetalkonium is based on the creation of a positive charge which permits a bio-adhesive property to negative surfaces. This property allows cetalkonium to disrupt the cell membrane, inactivate enzymes and denature proteins. This type of mechanism allows this type of agents to present a broad spectrum.